Showing results (501-510 of 2,330) with videos related to

Sort By:
Pageof 233
Clinical Drug Investigation|August 14, 2016
Disposition, Elimination and Haemodynamic Effects of Gallopamil in Patients with Fatty Liver DiseaseM Siepmann, B R Rao, W Kirch
Clinical Drug Investigation|August 14, 2016
Cefepime : The Last Generation or the First Enhanced-Potency Broad Spectrum Cephalosporin?C C Sanders, E S Moland
Clinical Drug Investigation|September 16, 2025
Effectiveness and Safety of Very-Low-Dose Rosuvastatin-Ezetimibe Therapy in Korean Patients with Dyslipidaemia: A Multicentre Prospective Observational StudyJi Woong Roh, Moon-Hwa Park, Ji-Won Son, et al.
Clinical Drug Investigation|August 26, 2021
Bempedoic Acid: A New Non-statin Drug for the Treatment of DyslipidemiaSurasak Wichaiyo, Wasu Supharattanasitthi
Clinical Drug Investigation|August 12, 2021
Moxetumomab Pasudotox in Hairy Cell Leukaemia: A Profile of Its UseConnie Kang
Clinical Drug Investigation|June 10, 2020
The Problem with AmphotericinGillian Cavell
Clinical Drug Investigation|July 14, 2025
Cost-Effectiveness of Adding Dapagliflozin and Empagliflozin to Standard Treatment for Diabetic Kidney Disease in ChinaTingting Qiu, Ping Li, Dan Yan
Clinical Drug Investigation|June 28, 2025
Pregabalin and Methadone Plasma Levels in Patients Receiving Methadone Maintenance Treatment: An Observational StudyAnat Sason, Miriam Adelson, Shaul Schreiber, et al.
Clinical Drug Investigation|December 19, 2024
Optimizing Individualized Antimicrobial Dosing in Pediatric Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsNadir Yalçın, Yağmur Dirik, İzgi Bayraktar, et al.
Clinical Drug Investigation|January 20, 2025
Safety, Tolerability, and Pharmacokinetics of a Novel Anti-obesity Agent, S-309309, in Healthy Adults with or Without ObesityToru Ishibashi, Hideki Tanioka, Tatsuya Ikehara, et al.
Pageof 233